Streetbeat News

Price Targets

ARHS

Piper Sandler analyst Peter Keith has maintained an Overweight rating on Arhaus (NASDAQ:ARHS) but lowered the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 9:18 pm

KPTI

Piper Sandler analyst Christopher Raymond has maintained an Overweight rating on Karyopharm Therapeutics (NASDAQ:KPTI) but lowered the price target from $7 to $5.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 9:16 pm

REGN

Piper Sandler analyst Christopher Raymond has maintained an 'Overweight' rating on Regeneron Pharmaceuticals and raised the price target from $885 to $895.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 9:14 pm

PCRX

Piper Sandler analyst David Amsellem maintains an Overweight rating on Pacira BioSciences (NASDAQ:PCRX) but lowers the price target from $50 to $42.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 9:12 pm

KYMR

Piper Sandler analyst Edward Tenthoff has maintained an Overweight rating on Kymera Therapeutics (NASDAQ:KYMR), but lowered the price target from $58 to $38.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 9:09 pm

HTGC

Piper Sandler analyst Crispin Love maintains an Overweight rating on Hercules Capital (NYSE:HTGC) but lowers the price target from $18.5 to $18.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 9:02 pm

SG

Piper Sandler analyst Brian Mullan maintains an Overweight rating on Sweetgreen (NYSE:SG) but has lowered the price target from $19 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:58 pm

PEN

Piper Sandler analyst Matt O'Brien has maintained an Overweight rating on Penumbra (NYSE:PEN) but lowered the price target from $335 to $250.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:56 pm

TRUP

Piper Sandler analyst John Barnidge maintains a Neutral rating on Trupanion (NASDAQ:TRUP) and lowers the price target from $32 to $28.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:54 pm

MCHP

Piper Sandler analyst Harsh Kumar has maintained an Overweight rating on Microchip Technology (NASDAQ:MCHP) but lowered the price target from $100 to $80.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:51 pm